{
Pfizer Inc.

Companies

}
Jim Cramer identifies market sectors needing a pullback after recent gains
Jim Cramer highlighted the extreme post-election market, noting sectors like enterprise software, subscription models, and banking that have surged but may need a pullback. He expressed caution over the rapid gains in stocks like Salesforce and Amazon, while also identifying pharmaceuticals and semiconductors as potentially undervalued sectors that could rebound. Cramer emphasized the need for clarity from the incoming administration before making investment decisions.
CNBC
Merck & Co., Inc. Amazon.com, Inc. Salesforce, Inc. Spotify Pfizer Inc. Netflix, Inc. Atlassian Corporation Costco ServiceNow, Inc. Workday, Inc. Datadog, Inc. Jim Cramer Robert F. Kennedy Jr. Donald Trump Show more
Finance & Economy, Market Report
00:57 15.11.2024
vaccine maker stocks decline after trump nominates rfk jr for hhs
Shares of vaccine manufacturers plummeted following President-elect Donald Trump's nomination of Robert F. Kennedy Jr., a noted vaccine skeptic, to lead the Department of Health and Human Services. Moderna, Novavax, Pfizer, and BioNTech all experienced significant declines, with Moderna down over 5% and Novavax falling more than 7%. Experts warn that Kennedy's influence could amplify anti-vaccine sentiments, potentially hindering vaccination efforts in the U.S.
CNBC
Euro United States Dollar Moderna, Inc. Novavax, Inc. GSK plc BioNTech SE Pfizer Inc. USA DEU Robert F. Kennedy Jr. Donald Trump Show more
Regulatory & Legal, Market Report
22:12 14.11.2024
Trump appoints RFK Jr. as Health Secretary amid vaccine skepticism
President-elect Donald Trump has appointed Robert F. Kennedy Jr. as the head of the Department of Health and Human Services, a decision that positions a well-known vaccine skeptic in a key federal health role. Trump emphasized the importance of protecting Americans from harmful substances, including chemicals and pharmaceuticals, which he claims contribute to the nation's health crisis. Following the announcement, vaccine stocks experienced a decline.
Bloomberg.com
Merck & Co., Inc. Pfizer Inc. USA Robert F. Kennedy Jr. Donald Trump
Regulatory & Legal, Press Release
21:34 14.11.2024
global efforts to combat antimicrobial resistance through incentives and collaboration
Canada is piloting an incentive program to combat antimicrobial resistance (AMR), with other nations like the UK and Japan exploring similar initiatives. Experts emphasize the need for a unified scientific approach to address AMR, highlighting the importance of prevention, regulation, and understanding community needs to ensure effective antibiotic use and animal health. Access to antibiotics is improving in low- and middle-income countries, but these regions are becoming hotspots for AMR, necessitating urgent action.
Health Policy Watch
Canadian Dollar Japanese Yen United States Dollar British Pound Sterling Euro Aurobac Therapeutics Pfizer Inc. BEAM Alliance GBR CAN ITA JPN SAU Arshnee Moodley Tamas Koncz Khumbize Kandodo Chiponda John-Arne Røttingen David Reddy Show more
Healthcare, News Article
21:23 14.11.2024
pfizer inc maintains strong market position with diverse product offerings
Pfizer Inc. is a leading global pharmaceutical company, with net sales primarily from primary care products (52.3%), specialty care products (25.6%), and oncology products (19.9%). Geographically, sales are distributed with 42.3% in the United States, 21.9% in Europe, and 33.8% in other regions.
MarketScreener
United States Dollar Pfizer Inc. USA
TradFi, Market Report
12:33 14.11.2024
ubs maintains neutral rating for pfizer with target price of 31 dollars
UBS has maintained a 'Neutral' rating for Pfizer, setting a target price of 31 US dollars. Analyst Trung Huynh noted that the pharmaceutical company is starting to regain investor confidence after a mixed performance this year.
MarketScreener
United States Dollar Pfizer Inc. USA Trung Huynh
TradFi, Market Report
12:30 14.11.2024
UBS maintains neutral rating for Pfizer with price target of 31 dollars
UBS has maintained a "Neutral" rating for Pfizer, setting a price target of $31 following a recent conference. Analyst Trung Huynh noted that despite a mixed performance this year, the pharmaceutical company is starting to regain investor confidence.
boerse.de
UBS AG Pfizer Inc. USA Hubert Dichtl Warren Buffet Trung Huynh Thomas Müller Show more
TradFi, Market Report
11:42 14.11.2024
Pfizer considers divesting hospital drugs unit amid investor pressure and debt concerns
Pfizer is considering selling its hospital drugs unit, formed after the $17 billion acquisition of Hospira in 2015, amid pressure from activist investor Starboard Value. The unit, which includes various sterile injectables, generates around $500 million in annual EBITDA and could be valued at several billion dollars. This move follows a significant decline in Pfizer's market value and ongoing debt reduction efforts, exacerbated by supply disruptions from a tornado that damaged a key manufacturing facility.
Fierce Pharma
United States Dollar The Goldman Sachs Group, Inc. ICU Medical, Inc. Pfizer Inc. USA Dave Denton Albert Bourla Show more
Finance & Economy, News Article
17:09 12.11.2024
global healthcare services market poised for significant growth through 2028
The global healthcare services market is projected to grow from $8,348.44 billion in 2023 to $8,963.64 billion in 2024, driven by advancements in medical technology, an aging population, and health insurance expansion. By 2028, it is expected to reach $10,908.99 billion, with key trends including telemedicine integration and patient-centered care. Shared medical appointments are gaining traction as a cost-effective model for managing chronic conditions, enhancing patient outcomes through collaborative care.
openPR.com
United States Dollar Community Health Systems, Inc. UnitedHealth Group Incorporated CVS Health Corporation Regeneron Pharmaceuticals, Inc. Cardinal Health, Inc. Fresenius Medical Care AG & Co. KGaA Centene Corporation Baxter International Inc. Mayo Clinic Agilent Technologies, Inc. Johnson & Johnson Pfizer Inc. Cleveland Clinic Global Solutions LLC McKesson Corporation Merck & Co., Inc. Abbott Laboratories Bristol-Myers Squibb Company Quest Diagnostics Incorporated HCA Healthcare, Inc. Gilead Sciences, Inc. Kaiser Permanente Group Trust Cigna Corporation Stryker Corporation Tenet Healthcare Corporation Danaher Corporation AbbVie Inc. Boston Scientific Corporation Molina Healthcare, Inc. Align Technology, Inc. AmerisourceBergen Corporation Laboratory Corporation OF America Holdings DaVita Inc. Eli Lilly and Company Humana Inc. West Pharmaceutical Services, Inc. Fresenius Medical Care AG & Co. KGaA Kaiser Permanente UnitedHealth Group Incorporated Tenet Healthcare HCA Healthcare Show more
Healthcare, Market Report
20:40 11.11.2024
pharmaceutical industry scandals and lobbying influence on public health decisions
Pharmaceutical giants like Pfizer and Moderna are profiting immensely from Covid-19 vaccines, with combined profits reaching $65,000 per minute. Despite their financial success, they have largely neglected low-income countries, delivering less than 1% of their vaccine stocks to these regions. The People's Vaccine Alliance highlights the urgent need for equitable vaccine distribution to combat "vaccine apartheid."
Infodujour.fr
United States Dollar Novartis AG Merck & Co., Inc. Moderna, Inc. GlaxoSmithKline Pfizer Inc. Takeda AbbVie Inc. Bristol Meyers Sanofi Hoffmann-La Roche AG Johnson & Johnson USA Jean-François Delfraissy Christian Perronne Arnaud Fontanet Robert Malone Didier Raoult Show more
Regulatory & Legal, News Article
15:20 11.11.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Banking Regulations Central Bank Actions Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Cryptocurrency & Blockchain Regulations Mergers & Acquisitions Cryptocurrency Developments Blockchain Technology Adoption Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Cryptocurrency Regulations Emerging Startups SEC & Financial Compliance Inflation Rates & CPI Data Banking & Investment Regulations
Countries:
USA CHE GBR DEU ARE HKG AUS JPN IND CHN CAN SGP DNK AUT LIE KOR NGA FIN COL VGB
Companies:
Credit Suisse Real Estate Fund Siat Coinbase Global, Inc. BlackRock, Inc. Solana USD Ripples USD Ethereum USD Apple Inc. Tesla, Inc. Fidelity Contrafund Cardano USD NVIDIA Corporation Grayscale Litecoin Trust Chainlink USD Tether USDt CNY Google Inc. Amazon.com, Inc. MicroStrategy Inc Franklin Templeton - Franklin M End Federal Reserve USD MicroStrategy Incorporated
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Indian Rupee Canadian Dollar Mozambican Metical British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Michael J. Saylor Gary Gensler Thomas Jordan Colm Kelleher Alan Santana Paul Atkins Joe Rogan Martin Schlegel Isabelle Chassot Mario Nawfal Paolo Ardoino Sergio Ermotti Dana White Joe Biden

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.